Search Results

There are 9705 results for: content related to: Automatic generation of case-detection algorithms to identify children with asthma from large electronic health record databases

  1. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Version of Record online : 8 JUN 2012, DOI: 10.1002/pds.3296

  2. Disease risk score as a confounder summary method: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 2, February 2013, Pages: 122–129, Mina Tadrous, Joshua J. Gagne, Til Stürmer and Suzanne M. Cadarette

    Version of Record online : 21 NOV 2012, DOI: 10.1002/pds.3377

  3. Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 718–728, Kueiyu Joshua Lin, Luis A. García Rodríguez and Sonia Hernández-Díaz

    Version of Record online : 27 MAY 2011, DOI: 10.1002/pds.2153

  4. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 396–406, Vibhu Paudyal, Denise Hansford, Scott Cunningham and Derek Stewart

    Version of Record online : 23 FEB 2012, DOI: 10.1002/pds.3219

  5. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1146–1153, Giulia P. Consiglio, Andrea M. Burden, Malcolm Maclure, Lisa McCarthy and Suzanne M. Cadarette

    Version of Record online : 13 SEP 2013, DOI: 10.1002/pds.3508

  6. Design of a score to identify hospitalized patients at risk of drug-related problems

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 9, September 2014, Pages: 923–932, Olatz Urbina, Olivia Ferrández, Santiago Grau, Sonia Luque, Sergi Mojal, Monica Marin-Casino, Javier Mateu-de-Antonio, Alexia Carmona, David Conde-Estévez, Merce Espona, Elena González, Marta Riu and Esther Salas

    Version of Record online : 10 MAY 2014, DOI: 10.1002/pds.3634

  7. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Version of Record online : 17 APR 2013, DOI: 10.1002/pds.3432

  8. Variable selection on large case-crossover data: application to a registry-based study of prescription drugs and road traffic crashes

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 140–151, Marta Avalos, Ludivine Orriols, Hélène Pouyes, Yves Grandvalet, Frantz Thiessard, Emmanuel Lagarde and on behalf of the CESIR research group

    Version of Record online : 18 OCT 2013, DOI: 10.1002/pds.3539

  9. Use of case–time–control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1159–1170, Sylvie D. Price, C. D'Arcy J. Holman, Frank M. Sanfilippo and Jon D. Emery

    Version of Record online : 25 JUN 2013, DOI: 10.1002/pds.3469

  10. Safety profile of oseltamivir during the 2009 influenza pandemic

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 532–543, Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

    Version of Record online : 29 MAR 2011, DOI: 10.1002/pds.2136

  11. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Version of Record online : 25 NOV 2015, DOI: 10.1002/pds.3912

  12. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 980–990, Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Version of Record online : 24 JUN 2015, DOI: 10.1002/pds.3820

  13. Statin use and the risk of developing diabetes: a network meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 10, October 2016, Pages: 1131–1149, Divyesh Thakker, Sunita Nair, Amit Pagada, Vinayak Jamdade and Anuradha Malik

    Version of Record online : 9 JUN 2016, DOI: 10.1002/pds.4020

  14. Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 8, August 2016, Pages: 871–879, Javier Cid Ruzafa, Evie Merinopoulou, Rebecca F. Baggaley, Pamela Leighton, Winifred Werther, Diana Felici and Andrew Cox

    Version of Record online : 19 JAN 2016, DOI: 10.1002/pds.3927

  15. Fifty years of pharmacovigilance – Medicines safety and public health

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 6, June 2016, Pages: 725–732, Joan-Ramon Laporte

    Version of Record online : 22 JAN 2016, DOI: 10.1002/pds.3967

  16. Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 4, April 2015, Pages: 435–445, Mir M. Ali, Catherine E. O'Brien, Mario A. Cleves and Bradley C. Martin

    Version of Record online : 12 FEB 2015, DOI: 10.1002/pds.3758

  17. Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 489–497, Supinya Dechanont, Sirada Maphanta, Bodin Butthum and Chuenjid Kongkaew

    Version of Record online : 10 MAR 2014, DOI: 10.1002/pds.3592

  18. You have full text access to this OnlineOpen article
    Methodological gaps in the assessment of risk minimization interventions: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 572–579, Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise and Yola Moride

    Version of Record online : 24 FEB 2014, DOI: 10.1002/pds.3596

  19. You have full text access to this OnlineOpen article
    Near real-time vaccine safety surveillance using electronic health records—a systematic review of the application of statistical methods

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 225–237, Andreia Leite, Nick J. Andrews and Sara L. Thomas

    Version of Record online : 28 JAN 2016, DOI: 10.1002/pds.3966

  20. Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 12, December 2015, Pages: 1259–1270, Diogo Mendes, Carlos Alves and Francisco Batel-Marques

    Version of Record online : 16 SEP 2015, DOI: 10.1002/pds.3874